OwlTail

Cover image of Robert Sidbury

Robert Sidbury

11 Podcast Episodes

Latest 24 Sep 2022 | Updated Daily

Episode artwork

Robert Sidbury, MD, MPH - Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Go online to PeerView.com/WVA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses team-based care and novel therapies in the treatment of pediatric patients with moderate to severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Describe age-related and race-related differences in the phenotypic expression of atopic dermatitis (AD); Employ evidence-based strategies to determine disease impact and guide treatment decisions in pediatric patients with AD; Discuss the rationale for targeting type 2 cytokines as a therapeutic approach in AD; Assess clinical data on new and emerging treatment options for pediatric patients with moderate to severe AD; and Employ a team-based and patient-centered management approach to children and adolescents with atopic dermatitis to prevent flare-ups, identify comorbidities, maximize health-related quality of life, and recognize treatment-related side effects.

39mins

1 Sep 2022

Episode artwork

Robert Sidbury, MD, MPH - Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?

PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

Go online to PeerView.com/WVA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses team-based care and novel therapies in the treatment of pediatric patients with moderate to severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Describe age-related and race-related differences in the phenotypic expression of atopic dermatitis (AD); Employ evidence-based strategies to determine disease impact and guide treatment decisions in pediatric patients with AD; Discuss the rationale for targeting type 2 cytokines as a therapeutic approach in AD; Assess clinical data on new and emerging treatment options for pediatric patients with moderate to severe AD; and Employ a team-based and patient-centered management approach to children and adolescents with atopic dermatitis to prevent flare-ups, identify comorbidities, maximize health-related quality of life, and recognize treatment-related side effects.

39mins

1 Sep 2022

Similar People

Episode artwork

Robert Sidbury, MD, MPH - Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?

PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/WVA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses team-based care and novel therapies in the treatment of pediatric patients with moderate to severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Describe age-related and race-related differences in the phenotypic expression of atopic dermatitis (AD); Employ evidence-based strategies to determine disease impact and guide treatment decisions in pediatric patients with AD; Discuss the rationale for targeting type 2 cytokines as a therapeutic approach in AD; Assess clinical data on new and emerging treatment options for pediatric patients with moderate to severe AD; and Employ a team-based and patient-centered management approach to children and adolescents with atopic dermatitis to prevent flare-ups, identify comorbidities, maximize health-related quality of life, and recognize treatment-related side effects.

39mins

1 Sep 2022

Episode artwork

Robert Sidbury, MD, MPH - Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?

PeerView Internal Medicine CME/CNE/CPE Video Podcast

Go online to PeerView.com/WVA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses team-based care and novel therapies in the treatment of pediatric patients with moderate to severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Describe age-related and race-related differences in the phenotypic expression of atopic dermatitis (AD); Employ evidence-based strategies to determine disease impact and guide treatment decisions in pediatric patients with AD; Discuss the rationale for targeting type 2 cytokines as a therapeutic approach in AD; Assess clinical data on new and emerging treatment options for pediatric patients with moderate to severe AD; and Employ a team-based and patient-centered management approach to children and adolescents with atopic dermatitis to prevent flare-ups, identify comorbidities, maximize health-related quality of life, and recognize treatment-related side effects.

42mins

1 Sep 2022

Most Popular

Episode artwork

Robert Sidbury, MD, MPH - Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?

PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast

Go online to PeerView.com/WVA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses team-based care and novel therapies in the treatment of pediatric patients with moderate to severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Describe age-related and race-related differences in the phenotypic expression of atopic dermatitis (AD); Employ evidence-based strategies to determine disease impact and guide treatment decisions in pediatric patients with AD; Discuss the rationale for targeting type 2 cytokines as a therapeutic approach in AD; Assess clinical data on new and emerging treatment options for pediatric patients with moderate to severe AD; and Employ a team-based and patient-centered management approach to children and adolescents with atopic dermatitis to prevent flare-ups, identify comorbidities, maximize health-related quality of life, and recognize treatment-related side effects.

42mins

1 Sep 2022

Episode artwork

Robert Sidbury, MD, MPH - Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?

PeerView Clinical Pharmacology CME/CNE/CPE Video

Go online to PeerView.com/WVA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses team-based care and novel therapies in the treatment of pediatric patients with moderate to severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Describe age-related and race-related differences in the phenotypic expression of atopic dermatitis (AD); Employ evidence-based strategies to determine disease impact and guide treatment decisions in pediatric patients with AD; Discuss the rationale for targeting type 2 cytokines as a therapeutic approach in AD; Assess clinical data on new and emerging treatment options for pediatric patients with moderate to severe AD; and Employ a team-based and patient-centered management approach to children and adolescents with atopic dermatitis to prevent flare-ups, identify comorbidities, maximize health-related quality of life, and recognize treatment-related side effects.

42mins

1 Sep 2022

Episode artwork

Robert Sidbury, MD, MPH - Intensifying the Identification and Treatment of Moderate-to-Severe AD: A Concerted Look at Aligning Patients and Therapy

CME in Minutes: Education in Dermatology

Please visit answersincme.com/RKA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pediatric dermatology discusses identifying and treating moderate-to-severe atopic dermatitis (AD) using two patient cases. Upon completion of this activity, participants should be better able to: Identify patients who have moderate-to-severe AD and may benefit from intensified therapy; Outline the latest evidence for biologic therapies that may be used for the treatment of patients with moderate-to-severe AD now and into the future; and Apply practical approaches to optimize the management of patients with moderate-to-severe AD long-term.

14mins

19 Jul 2022

Episode artwork

Robert Sidbury, MD, MPH - Intensifying the Identification and Treatment of Moderate-to-Severe AD: A Concerted Look at Aligning Patients and Therapy

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases

Please visit answersincme.com/RKA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pediatric dermatology discusses identifying and treating moderate-to-severe atopic dermatitis (AD) using two patient cases. Upon completion of this activity, participants should be better able to: Identify patients who have moderate-to-severe AD and may benefit from intensified therapy; Outline the latest evidence for biologic therapies that may be used for the treatment of patients with moderate-to-severe AD now and into the future; and Apply practical approaches to optimize the management of patients with moderate-to-severe AD long-term.

14mins

19 Jul 2022

Episode artwork

Robert Sidbury, MD, MPH - Intensifying the Identification and Treatment of Moderate-to-Severe AD: A Concerted Look at Aligning Patients and Therapy

CME in Minutes: Education in Primary Care

Please visit answersincme.com/RKA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pediatric dermatology discusses identifying and treating moderate-to-severe atopic dermatitis (AD) using two patient cases. Upon completion of this activity, participants should be better able to: Identify patients who have moderate-to-severe AD and may benefit from intensified therapy; Outline the latest evidence for biologic therapies that may be used for the treatment of patients with moderate-to-severe AD now and into the future; and Apply practical approaches to optimize the management of patients with moderate-to-severe AD long-term.

14mins

19 Jul 2022

Episode artwork

SDPA Summer 2018 | Pediatric Atopic Dermatitis with Robert Sidbury, MD

Dermcast.tv Dermatology Podcasts

Robert Sidbury, MD stopped by the Dermcast studios during the SDPA’s Annual Summer Dermatology Conference 2018, held in Seattle, Washington, to discuss atopic dermatitis.

29 Oct 2018

Loading